Relenza Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsors:   GlaxoSmithKline;   GlaxoSmithKlineActive, not recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsors:   GlaxoSmithKline;   GlaxoSmithKlineCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsor:   GlaxoSmithKlineCompleted - verified June 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsor:   GlaxoSmithKlineCompleted - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Condition:   Influenza, HumanInterventions:   Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placeboSponsor:   GlaxoSmithKlineRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2010 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Condition:   Influenza, HumanInterventions:   Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placeboSponsor:   GlaxoSmithKlineRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2010 Category: Research Source Type: clinical trials